CTIBIOTECH Develops Novel 3D Bioprinting Platform to Treat Colon Cancer
Regenerative medicine firm CTIBIOTECH has developed a new 3D bioprinting platform to deliver personalized medicine for patients with colorectal cancer.
News and Insights of 3D Printing and Manufacturing
Homebioprinting
Regenerative medicine firm CTIBIOTECH has developed a new 3D bioprinting platform to deliver personalized medicine for patients with colorectal cancer.
Bioconvergence company BICO is partnering with Nanochon, a startup developing regenerative joint replacements. Under the terms of the deal, Nanochon will purchase $1.5 million worth of products and services from BICO’s SCIENION to develop 3D printed regenerative joint implants. Nanochon’s novel joint implant technology promises to deliver faster and more successful recoveries for patients while reducing costs to health providers, payers, and patients.
Scientists at the Irish RCSI University of Medicine and Health Sciences have developed a novel bio-ink that can be 3D printed into tissues capable of fast-forwarding the human wound-healing process.
Fluicell, a Sweden-based bioprinting startup founded in 2012 as a spin-out of the Chalmers University of Technology, has undertaken research to develop medicinal products for treating type 1 diabetes. The project, which recently achieved a significant milestone, is based on biocomposite tissues generated by Fluicell’s Biopixlar system.
Bioprinting company T&R Biofab and B Braun, a major healthcare solutions provider, held a joint presentation to launch T&R’s new 3D printed PCL Craniofacial bone implants products. The event, hosted by B Braun Korea was held at the Dragon City Hotel in Seoul.
The PhonoGraft biomimetic hearing-restoration technology, advanced through a six-year effort by a multidisciplinary research team at the Wyss Institute for Biologically Inspired Engineering, Harvard’s John A. Paulson School of Engineering and Applied Sciences (SEAS), and Massachusetts Eye and Ear (MEE)/Mass General Brigham (MGB), has now entered commercial development. If successful, it could mitigate pain, drainage, and hearing loss associated with eardrum perforations that affect millions of individuals worldwide.
Nominations for the 2021 3D Printing Industry Awards are now open, have your say who is leading the industry now.
FluidForm, an expert in the field of human tissue for research, repair, and replacement signed an agreement with Ethicon, a member of the Johnson & Johnson Medical Devices Companies, to develop 3D bioprinted applications using FluidForm’s patented FRESH technology. This collaboration leverages FluidForm’s FRESH 3D bioprinting platform to achieve specific tissue characteristics that cannot be manufactured with conventional techniques.
3D printer manufacturer 3D Systems has announced a co-development agreement with CollPlant, a regenerative medicine firm, to develop 3D bioprinted soft tissue structures for breast reconstruction treatments.
Researchers at the Baylor College of Medicine used a 3D bioprinter to fabricate a Biomesh using a polymer called phosphate cross-linked poly (vinyl alcohol) polymer (X-PVA) for an innovative new treatment of hernias. The complete study was published in Advanced Materials.